(Q40062188)

30 June 2019

title

Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication (English)

1 reference

30 June 2019

0 references

1 reference

Ralf Bartenschlager

8

0 references

Rolf Hilgenfeld

7

object named as

Rolf Hilgenfeld

1 reference

30 June 2019

author name string

Jenny Kouretova

1

1 reference

30 June 2019

M Zouhir Hammamy

2

1 reference

30 June 2019

Anton Epp

3

1 reference

30 June 2019

Kornelia Hardes

4

1 reference

30 June 2019

Stephanie Kallis

5

1 reference

30 June 2019

Linlin Zhang

6

1 reference

30 June 2019

Torsten Steinmetzer

9

1 reference

30 June 2019

language of work or name

1 reference

1 December 2017

1 reference

30 June 2019

Journal of Enzyme Inhibition and Medicinal Chemistry

published in

1 reference

30 June 2019

volume

32

1 reference

30 June 2019

issue

1

1 reference

30 June 2019

page(s)

712-721

1 reference

30 June 2019

Creative Commons Attribution 4.0 International

copyright license

start time

1 January 2017

1 reference

https://api.crossref.org/v1/works/10.1080/14756366.2017.1306521

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The global distribution and burden of dengue

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

West Nile virus infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Trials and tribulations on the path to developing a dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Efficacy of a tetravalent dengue vaccine in children in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Status of vaccine research and development of vaccines for dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Ten years of dengue drug discovery: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

West Nile virus drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Biochemistry and medicinal chemistry of the dengue virus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Switching the Substrate Specificity of the Two-Component NS2B-NS3 Flavivirus Proteinase by Structure-Based Mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

The biology and therapeutic targeting of the proprotein convertases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B/NS3 serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Novel agmatine dipeptide inhibitors against the West Nile virus NS2B/NS3 protease: a P3 and N-cap optimization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

A new strategy for the development of highly potent and selective plasmin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Novel Furin Inhibitors with Potent Anti-infectious Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Purification and crystallization of dengue and West Nile virus NS2B–NS3 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

The determination of enzyme inhibitor constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Flaviviruses and their antigenic structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Internalization of cationic peptides: the road less (or more?) traveled

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Cell-penetrating peptides: classes, origin, and current landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Structural evidence for regulation and specificity of flaviviral proteases and evolution of theFlaviviridaefold

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Refined structure of the hirudin-thrombin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Novel dengue virus NS2B/NS3 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

The Medicinal Chemistry of Dengue Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

Racemisation of N-Fmoc phenylglycine under mild microwave-SPPS and conventional stepwise SPPS conditions: attempts to develop strategies for overcoming this

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756366.2017.1306521

10.1080/14756366.2017.1306521

21 January 2018

Identifiers

DOI

1 reference

30 June 2019

PMC publication ID

6445162

1 reference

30 June 2019

PubMed publication ID

28385094

1 reference

30 June 2019